GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Allos Therapeutics, Inc. (ALTH) [hlAlert]

Allos Therapeutics is a pharmaceutical company focused on developing andcommercializing innovative small molecule drugs, initially for
improving cancer treatments. The company's lead product candidate is RSR13. RSR13 is a synthetic small molecule that increases the release of oxygen from hemoglobin, the oxygen-carrying protein contained within red blood cells.
( Total: 15 Current Stock Recommendations )
Allos Therapeutics, Inc.   (15)
Hold 33% Buy 67%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Hold ALTH
down 60.00 %

Rating:
Hold ALTH

Rating:
Buy ALTH
down 61.50 %

Rating:
Hold ALTH
down 71.80 %
Allos Therapeutics, Inc. (ALTH) downgraded to Hold by Needham
Wednesday,  May 11, 2011  8:25 AM ET

Rating:
Buy ALTH
down 61.50 %

Rating:
Buy ALTH
down 60.00 %

Rating:
Buy ALTH
down 74.15 %
Allos Therapeutics, Inc. (ALTH) rated Overweight by JP Morgan
Friday,  Jan 8, 2010  8:25 AM ET

Rating:
Buy ALTH
down 70.79 %
Allos Therapeutics, Inc. (ALTH) rated Buy by ThinkEquity
Tuesday,  Nov 24, 2009  8:25 AM ET

Rating:
Buy ALTH
down 76.01 %

Rating:
Hold ALTH

Rating:
Buy ALTH
down 66.48 %

Rating:
Buy ALTH
down 69.07 %

Rating:
Buy ALTH
down 69.88 %

Rating:
Buy ALTH
down 71.80 %

Your Recent Stocks
SymbolLastChange
ALTH 1.84   0.00 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy